Gouty arthritis: Understanding the disease state and management options in primary care
- 31 August 2011
- journal article
- review article
- Published by Springer Nature in Advances in Therapy
- Vol. 28 (9) , 748-760
Abstract
Acute gouty arthritis is an inflammatory response triggered by the release of monosodium urate crystal deposits into the joint space. The disease is associated with debilitating clinical symptoms and functional impairments as well as adverse economic and quality-of-life burdens. Because gouty arthritis is typically diagnosed and managed in the primary care setting, clinicians require a thorough knowledge of the presenting clinical features, risk factors, differential diagnoses, and treatment options for appropriate management. Although generally effective, the use of currently available therapies to control gouty arthritis is challenging because many medications used to treat comorbidities can exacerbate gouty arthritis and because current agents are associated with a number of adverse events, contraindications, or both. Based on an understanding of the underlying inflammatory pathogenesis of gouty arthritis, several new agents are being developed that may provide improved efficacy.Keywords
This publication has 25 references indexed in Scilit:
- A Diagnostic Rule for Acute Gouty Arthritis in Primary Care Without Joint Fluid AnalysisArchives of internal medicine (1960), 2010
- Update on Biology: Uric Acid and the Activation of Immune and Inflammatory CellsCurrent Rheumatology Reports, 2010
- Perceptions of disease and health-related quality of life among patients with goutRheumatology, 2008
- The gout diagnosisCleveland Clinic Journal of Medicine, 2008
- Independent Impact of Gout on Mortality and Risk for Coronary Heart DiseaseCirculation, 2007
- Updates in the Management of GoutThe American Journal of Medicine, 2007
- EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT)Annals of the Rheumatic Diseases, 2006
- Gout-associated uric acid crystals activate the NALP3 inflammasomeNature, 2006
- A concise history of gout and hyperuricemia and their treatmentArthritis Research & Therapy, 2006
- Epidemiology, risk factors, and lifestyle modifications for goutArthritis Research & Therapy, 2006